Kimia Farma Tbk PT
IDX:KAEF
Kimia Farma Tbk PT
IDX:KAEF
Price:
600
IDR
Market Closed
Market Cap:
3.3T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
KAEF Alert
Kimia Farma Tbk PT
600
0 (0%)
| 52 Week Range |
560
1 550
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Kimia Farma Tbk PT
Balance Sheet
Balance Sheet Decomposition
Kimia Farma Tbk PT
Kimia Farma Tbk PT
| Current Assets | 5.3T |
| Cash & Short-Term Investments | 505.1B |
| Receivables | 2.3T |
| Other Current Assets | 2.5T |
| Non-Current Assets | 11.6T |
| Long-Term Investments | 1.1T |
| PP&E | 10.1T |
| Intangibles | 168.9B |
| Other Non-Current Assets | 228B |
| Current Liabilities | 7.8T |
| Accounts Payable | 1.7T |
| Accrued Liabilities | 513.5B |
| Short-Term Debt | 4.1T |
| Other Current Liabilities | 1.5T |
| Non-Current Liabilities | 3.7T |
| Long-Term Debt | 2.4T |
| Other Non-Current Liabilities | 1.3T |
Balance Sheet
Kimia Farma Tbk PT
Kimia Farma Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
263 360
|
250 994
|
230 684
|
1 136 682
|
857 565
|
526 168
|
1 249 994
|
742 581
|
2 153 024
|
832 672
|
|
| Cash |
263 360
|
236 717
|
230 684
|
0
|
857 565
|
526 168
|
994 994
|
744 119
|
2 152 628
|
829 276
|
|
| Cash Equivalents |
0
|
14 277
|
0
|
1 136 682
|
0
|
0
|
255 000
|
1 538
|
395
|
3 396
|
|
| Short-Term Investments |
310 000
|
210 000
|
417 000
|
0
|
1 211 100
|
834 100
|
255 000
|
5 900
|
400
|
3 400
|
|
| Total Receivables |
0
|
0
|
733 056
|
1 340 365
|
1 421 651
|
2 325 129
|
1 760 955
|
2 193 497
|
2 349 408
|
2 097 521
|
|
| Accounts Receivables |
0
|
0
|
710 032
|
1 291 306
|
1 325 117
|
2 116 727
|
1 526 705
|
1 943 935
|
1 829 080
|
1 815 229
|
|
| Other Receivables |
0
|
0
|
23 024
|
49 060
|
96 535
|
208 402
|
234 250
|
249 561
|
520 327
|
282 292
|
|
| Inventory |
0
|
0
|
967 327
|
1 350 993
|
2 126 016
|
2 849 106
|
2 455 829
|
2 690 960
|
2 941 267
|
2 481 581
|
|
| Other Current Assets |
0
|
0
|
558 671
|
599 555
|
761 676
|
810 283
|
626 326
|
567 825
|
698 053
|
474 888
|
|
| Total Current Assets |
0
|
0
|
2 906 737
|
4 427 595
|
6 378 008
|
7 344 787
|
6 093 104
|
6 200 763
|
8 179 803
|
5 886 663
|
|
| PP&E Net |
0
|
0
|
1 006 925
|
2 074 085
|
3 315 148
|
9 279 811
|
9 800 612
|
9 974 355
|
10 088 554
|
10 137 821
|
|
| PP&E Gross |
0
|
0
|
1 006 925
|
0
|
3 315 148
|
9 279 811
|
9 800 612
|
9 974 355
|
10 088 554
|
10 137 821
|
|
| Accumulated Depreciation |
456 237
|
491 879
|
541 240
|
0
|
890 237
|
1 038 802
|
1 249 687
|
1 783 275
|
2 207 240
|
2 919 188
|
|
| Intangible Assets |
0
|
0
|
3 539
|
10 493
|
48 624
|
50 943
|
54 649
|
58 879
|
60 428
|
62 363
|
|
| Goodwill |
0
|
0
|
0
|
0
|
134 444
|
134 444
|
134 444
|
134 444
|
134 444
|
107 555
|
|
| Note Receivable |
0
|
0
|
2 693
|
3 119
|
3 191
|
9 989
|
5 040
|
6 396
|
2 904
|
291
|
|
| Long-Term Investments |
0
|
0
|
439 550
|
508 470
|
1 106 779
|
1 195 996
|
1 179 646
|
1 239 737
|
1 219 941
|
1 242 443
|
|
| Other Long-Term Assets |
0
|
0
|
253 117
|
248 322
|
342 897
|
336 907
|
295 321
|
145 621
|
111 248
|
148 162
|
|
| Other Assets |
0
|
0
|
0
|
0
|
134 444
|
134 444
|
134 444
|
134 444
|
134 444
|
107 555
|
|
| Total Assets |
0
N/A
|
0
N/A
|
4 612 563
N/A
|
7 272 085
+58%
|
11 329 091
+56%
|
18 352 877
+62%
|
17 562 817
-4%
|
17 760 195
+1%
|
19 797 323
+11%
|
17 585 298
-11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
895 126
|
982 677
|
1 281 733
|
1 290 414
|
1 288 288
|
786 453
|
1 468 466
|
1 561 399
|
|
| Accrued Liabilities |
0
|
0
|
257 638
|
279 685
|
286 936
|
179 115
|
165 799
|
244 841
|
366 215
|
399 449
|
|
| Short-Term Debt |
0
|
0
|
443 237
|
850 536
|
2 784 536
|
5 226 775
|
4 379 678
|
3 631 865
|
4 304 587
|
5 374 814
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1 447
|
306 013
|
218 521
|
545 623
|
787 780
|
1 143 321
|
2 104 330
|
1 563 266
|
|
| Other Current Liabilities |
0
|
0
|
98 761
|
135 322
|
174 116
|
150 213
|
165 397
|
173 700
|
447 666
|
510 807
|
|
| Total Current Liabilities |
0
|
0
|
1 696 209
|
2 554 232
|
4 745 842
|
7 392 140
|
6 786 942
|
5 980 181
|
8 691 264
|
9 409 735
|
|
| Long-Term Debt |
0
|
0
|
377 714
|
1 095 838
|
1 867 146
|
2 524 260
|
2 593 487
|
3 248 755
|
1 705 008
|
762 935
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
163 567
|
568 917
|
438 131
|
414 647
|
489 567
|
158 515
|
|
| Minority Interest |
0
|
0
|
50 451
|
62 248
|
154 465
|
171 033
|
112 275
|
92 229
|
865 123
|
504 644
|
|
| Other Liabilities |
0
|
0
|
267 232
|
348 104
|
406 277
|
454 634
|
638 585
|
884 741
|
908 728
|
861 408
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
2 391 606
N/A
|
4 060 421
+70%
|
7 337 298
+81%
|
11 110 983
+51%
|
10 569 420
-5%
|
10 620 552
+0%
|
12 659 690
+19%
|
11 697 236
-8%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
555 400
|
555 400
|
555 400
|
555 400
|
555 400
|
555 400
|
555 400
|
556 649
|
|
| Retained Earnings |
0
|
0
|
1 672 567
|
1 945 868
|
2 263 680
|
2 456 905
|
2 291 237
|
2 586 455
|
2 377 092
|
891 529
|
|
| Additional Paid In Capital |
0
|
0
|
43 580
|
77 521
|
77 521
|
885 401
|
885 401
|
885 401
|
894 171
|
882 617
|
|
| Other Equity |
0
|
0
|
50 590
|
632 874
|
1 095 192
|
5 114 990
|
5 032 162
|
4 883 190
|
5 099 311
|
5 322 501
|
|
| Total Equity |
0
N/A
|
0
N/A
|
2 220 956
N/A
|
3 211 663
+45%
|
3 991 793
+24%
|
7 241 894
+81%
|
6 993 397
-3%
|
7 139 643
+2%
|
7 137 633
0%
|
5 888 062
-18%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
4 612 563
N/A
|
7 272 085
+58%
|
11 329 091
+56%
|
18 352 877
+62%
|
17 562 817
-4%
|
17 760 195
+1%
|
19 797 323
+11%
|
17 585 298
-11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
5 554
|
5 554
|
5 554
|
5 554
|
5 554
|
5 554
|
5 554
|
5 566
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
